Compare the most recent clinical trial data, real-world evidence, and ongoing clinical trial programs for BTK and BCL-2 inhibitors in the treatment of CLL/SLL Evaluate the utility of molecular profiling, MRD evaluation, and therapeutic sequencing for patients with CLL/SLL Integrate effective risk stratification techniques to evaluate individual patient presentations and personalize treatment plans for patients affected by CLL/SLL
- Provider:HMP Education
- Activity Link: https://www.hmpeducation.com/program/24-gduhem-102
- Start Date: 2024-08-29 05:00:00
- End Date: 2024-08-29 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.75 hours
AMA PRA Category 1 Credit™️: 0.75 hours
Nursing: 0.75 hours
Pharmacy: 0.75 hours - MOC Credit Details: ABS - 0.75 Point; Credit Type(s): Accredited CME (ABS)
- Commercial Support: Source: AbbVie (Any division) - Amount: 0 - Is Kind Support: False Source: AstraZeneca (Any division) - Amount: 0 - Is Kind Support: False Source: BeiGene USA - Amount: 0 - Is Kind Support: False Source: Janssen (Any division) - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery
Subscribe
Login
0 Comments
Oldest